TransAlgae Raises Additional $2.5M For Algae-Based Oral Vaccine Solution
The firm says the round provides 'a strong vote of confidence' in TransAlgae’s disruptive microalgae-based oral delivery tech.
April 18, 2021
Sponsored by the Asper Foundation and Reichman University
